tiprankstipranks
Trending News
More News >
Iperionx Ltd. ADR (IPX)
:IPX
Advertisement

Iperionx Ltd. ADR (IPX) AI Stock Analysis

Compare
56 Followers

Top Page

IPX

Iperionx Ltd. ADR

(NASDAQ:IPX)

Rating:35Underperform
Price Target:
Iperionx Ltd. ADR faces significant financial challenges with no revenue and consistent net losses, raising doubts about its long-term viability. Technically, the stock is in a bearish trend, though there are some neutral indicators. The negative P/E ratio and absence of a dividend yield further weigh on the stock's valuation. These factors combine to suggest caution for potential investors.

Iperionx Ltd. ADR (IPX) vs. SPDR S&P 500 ETF (SPY)

Iperionx Ltd. ADR Business Overview & Revenue Model

Company DescriptionIperionX Limited engages in the exploration and development of mineral properties. It explores for epithermal and replacement style precious and base metal mineralization, as well as titanium, rare earth elements, silica sand, and zircon minerals. The company holds a 100% interest in the Milford project that includes 101 claims located in Utah, the United States. It also holds a 100% interest in Titan project covering an area of approximately 6,000 acres situated in Tennessee, the United States. The company was formerly known as Hyperion Metals Limited and changed its name to IperionX Limited in February 2022. IperionX Limited was incorporated in 2017 and is headquartered in Charlotte, North Carolina.
How the Company Makes MoneyIperionx Ltd. generates revenue by producing and selling titanium metal powders and related products to industrial clients. The company's revenue model is primarily based on the sale of these advanced materials, which are in demand due to their lightweight, durable, and corrosion-resistant properties. Key revenue streams include contracts and sales agreements with manufacturers in sectors such as aerospace and automotive, where titanium's high performance is critical. Additionally, Iperionx may engage in partnerships and collaborations with other companies to enhance their product offerings and expand their market reach. The company's earnings are also influenced by their ability to innovate and improve production processes, thereby reducing costs and increasing profitability.

Iperionx Ltd. ADR Financial Statement Overview

Summary
Iperionx Ltd. ADR faces significant operational challenges with no revenue generation and continued net losses, raising concerns about long-term viability. While the balance sheet shows low leverage, the reliance on external financing underscores the need for strategic shifts to achieve profitability and growth.
Income Statement
10
Very Negative
The company has reported no revenue over several years, indicating a lack of operational sales activity. This persistent absence of revenue and the negative net income suggest significant challenges in generating profits.
Balance Sheet
40
Negative
The company maintains a strong equity position with a low debt-to-equity ratio, implying minimal financial leverage. However, the lack of revenue generation and recurring net losses raise concerns about the sustainability of its financial structure.
Cash Flow
30
Negative
The company consistently reports negative operating cash flow and free cash flow, highlighting challenges in cash generation. Nonetheless, there is a positive trend in financing cash flow, suggesting reliance on external funding to sustain operations.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue0.000.000.000.000.00
Gross Profit-634.11K-211.58K
EBITDA-22.49M-25.62M-29.39M-13.30M
Net Income-22.23M-25.93M-21.52M
Balance Sheet
Total Assets55.44M34.26M9.91M3.72M
Cash, Cash Equivalents and Short-Term Investments33.16M17.93M5.67M1.70M
Total Debt1.49M1.47M543.03K475.65K
Total Liabilities4.10M3.37M2.49M762.50K
Stockholders Equity51.34M30.89M7.42M1.76M
Cash Flow
Free Cash Flow-26.68M-18.57M-14.06M-3.62M
Operating Cash Flow-18.68M-15.86M-12.13M-3.56M
Investing Cash Flow-6.53M-5.71M-3.07M1.76M
Financing Cash Flow46.59M27.89M19.39M3.50M

Iperionx Ltd. ADR Technical Analysis

Technical Analysis Sentiment
Positive
Last Price36.25
Price Trends
50DMA
27.96
Positive
100DMA
23.71
Positive
200DMA
25.20
Positive
Market Momentum
MACD
2.55
Negative
RSI
77.65
Negative
STOCH
85.56
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IPX, the sentiment is Positive. The current price of 36.25 is above the 20-day moving average (MA) of 32.10, above the 50-day MA of 27.96, and above the 200-day MA of 25.20, indicating a bullish trend. The MACD of 2.55 indicates Negative momentum. The RSI at 77.65 is Negative, neither overbought nor oversold. The STOCH value of 85.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IPX.

Iperionx Ltd. ADR Risk Analysis

Iperionx Ltd. ADR disclosed 51 risk factors in its most recent earnings report. Iperionx Ltd. ADR reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Iperionx Ltd. ADR Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
$10.83B-9.62%4.63%-3189.81%
57
Neutral
$444.25M-4.38%105.14%84.95%
55
Neutral
$886.47M27.86-7.29%1.14%-4.98%-192.96%
44
Neutral
C$979.11M-6.81-13.73%1.81%17.37%-32.84%
35
Underperform
$1.33B-40.55%-15.85%
$447.65M-303.62%
$1.23B15.7953.85%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IPX
Iperionx Ltd. ADR
40.88
26.04
175.47%
GSM
Ferroglobe
4.57
-0.79
-14.74%
UAMY
United States Antimony
3.60
3.25
928.57%
MP
MP Materials
61.56
47.66
342.88%
CRML
Critical Metals Corp
4.23
-5.92
-58.33%
USAR
USA Rare Earth
12.30
1.64
15.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 20, 2025